Works matching IS 00070920 AND DT 2017 AND VI 116 AND IP 10


Results: 15
    1
    2
    3
    4

    Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study.

    Published in:
    British Journal of Cancer, 2017, v. 116, n. 10, p. 1287, doi. 10.1038/bjc.2017.83
    By:
    • Phelps, David L;
    • Borley, Jane V;
    • Flower, Kirsty J;
    • Dina, Roberto;
    • Darb-Esfahani, Silvia;
    • Braicu, Ioana;
    • Sehouli, Jalid;
    • Fotopoulou, Christina;
    • Wilhelm-Benartzi, Charlotte S;
    • Gabra, Hani;
    • Yazbek, Joseph;
    • Chatterjee, Jayanta;
    • Ip, Jacey;
    • Khan, Harun;
    • Likos-Corbett, Marina-Therese;
    • Brown, Robert;
    • Ghaem-Maghami, Sadaf
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis.

    Published in:
    British Journal of Cancer, 2017, v. 116, n. 10, p. 1247, doi. 10.1038/bjc.2017.67
    By:
    • Pelzer, Uwe;
    • Blanc, Jean-Frédéric;
    • Melisi, Davide;
    • Cubillo, Antonio;
    • Von Hoff, Daniel D;
    • Wang-Gillam, Andrea;
    • Chen, Li-Tzong;
    • Siveke, Jens T;
    • Wan, Yin;
    • Solem, Caitlyn T;
    • Botteman, Marc F;
    • Yang, Yoojung;
    • de Jong, Floris A;
    • Hubner, Richard A
    Publication type:
    Article
    11
    12
    13
    14
    15